Biotech

All Articles

Fierce Biotech's Gabrielle Masson shows Tough 15 at NYSE

.Strong Biotech Associate Editor Gabrielle Masson offered the 2024 class of Tough 15 victors on the ...

Novo Nordisk centers once-monthly GLP-1\/ GIP agonist, MASH prospect

.Novo Nordisk has axed its once-monthly dual GLP-1/ GIP receptor agonist, ending (PDF) advancement o...

Daiichi pays out Merck $170M to create lung cancer T-cell engager pact

.Merck &amp Co. has actually rapidly recovered several of the expenses of its Spear Therapeutics pur...

BioMarin stops preclinical genetics therapy for heart condition

.After BioMarin conducted a spring season well-maintained of its own pipeline in April, the firm has...

Eisai plants molecular glue SEED along with $1.5 B biobucks work

.Big Pharmas remain caught to the concept of molecular glue degraders. The most up to date business ...

Life science credit rating company unveils along with $600M

.A brand new worldwide life scientific research debt firm, termed Symbiotic Capital, has actually in...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing an additional major wager coming from the Caforio time, term...

Nuvation halts BET inhibitor after considering phase 1 information

.After having a look at phase 1 data, Nuvation Biography has actually determined to halt work on its...

' Clinical instinct' led FDA consultants to back Zevra's uncommon health condition med

.Zevra Therapeutics' rare condition medication seems to be to become on the course to approval this ...

Pfizer takes $230M struck after axing stopped working DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics therapy breakdown has blown a $230 millio...